Mark J. Ratain to Soft Tissue Neoplasms
This is a "connection" page, showing publications Mark J. Ratain has written about Soft Tissue Neoplasms.
Connection Strength
0.100
-
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial. Invest New Drugs. 2011 Jun; 29(3):481-8.
Score: 0.080
-
A limited sampling strategy for cyclophosphamide pharmacokinetics. Cancer Res. 1989 Jun 01; 49(11):3129-33.
Score: 0.019